nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.08	0.137	CbGbCtD
Methylphenidate—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0752	0.129	CbGbCtD
Methylphenidate—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0752	0.129	CbGbCtD
Methylphenidate—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.068	0.116	CbGbCtD
Methylphenidate—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.068	0.116	CbGbCtD
Methylphenidate—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0587	0.1	CbGbCtD
Methylphenidate—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.057	0.0974	CbGbCtD
Methylphenidate—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0515	0.0881	CbGbCtD
Methylphenidate—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0515	0.0881	CbGbCtD
Methylphenidate—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00418	0.146	CbGeAlD
Methylphenidate—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00337	0.118	CbGeAlD
Methylphenidate—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.0029	0.101	CbGeAlD
Methylphenidate—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.0014	0.0488	CbGeAlD
Methylphenidate—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.00112	0.039	CbGeAlD
Methylphenidate—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.00111	0.0389	CbGeAlD
Methylphenidate—SLC6A4—blood—acquired immunodeficiency syndrome	0.00106	0.037	CbGeAlD
Methylphenidate—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.00102	0.0357	CbGeAlD
Methylphenidate—SLC6A3—lung—acquired immunodeficiency syndrome	0.00102	0.0354	CbGeAlD
Methylphenidate—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.00094	0.0328	CbGeAlD
Methylphenidate—SLC6A4—lung—acquired immunodeficiency syndrome	0.000931	0.0325	CbGeAlD
Methylphenidate—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000905	0.0316	CbGeAlD
Methylphenidate—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000862	0.0301	CbGeAlD
Methylphenidate—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.00083	0.029	CbGeAlD
Methylphenidate—SLC6A2—lung—acquired immunodeficiency syndrome	0.000819	0.0286	CbGeAlD
Methylphenidate—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000759	0.0265	CbGeAlD
Methylphenidate—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.00073	0.0255	CbGeAlD
Methylphenidate—SLC6A3—brain—acquired immunodeficiency syndrome	0.000719	0.0251	CbGeAlD
Methylphenidate—SLC6A4—brain—acquired immunodeficiency syndrome	0.000659	0.023	CbGeAlD
Methylphenidate—SLC6A2—brain—acquired immunodeficiency syndrome	0.00058	0.0202	CbGeAlD
Methylphenidate—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.00056	0.0196	CbGeAlD
Methylphenidate—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000537	0.0187	CbGeAlD
Methylphenidate—CYP2D6—blood—acquired immunodeficiency syndrome	0.000512	0.0179	CbGeAlD
Methylphenidate—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000415	0.0145	CbGeAlD
Methylphenidate—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.0004	0.014	CbGeAlD
Methylphenidate—CYP2D6—brain—acquired immunodeficiency syndrome	0.000318	0.0111	CbGeAlD
Methylphenidate—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000399	CcSEcCtD
Methylphenidate—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000399	CcSEcCtD
Methylphenidate—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000398	CcSEcCtD
Methylphenidate—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000397	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000397	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000396	CcSEcCtD
Methylphenidate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000153	0.000395	CcSEcCtD
Methylphenidate—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000395	CcSEcCtD
Methylphenidate—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000395	CcSEcCtD
Methylphenidate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000395	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000395	CcSEcCtD
Methylphenidate—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000394	CcSEcCtD
Methylphenidate—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000394	CcSEcCtD
Methylphenidate—Pain—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000392	CcSEcCtD
Methylphenidate—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000392	CcSEcCtD
Methylphenidate—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000392	CcSEcCtD
Methylphenidate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000392	CcSEcCtD
Methylphenidate—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000392	CcSEcCtD
Methylphenidate—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000391	CcSEcCtD
Methylphenidate—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.00039	CcSEcCtD
Methylphenidate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.00039	CcSEcCtD
Methylphenidate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.00039	CcSEcCtD
Methylphenidate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00015	0.000389	CcSEcCtD
Methylphenidate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000389	CcSEcCtD
Methylphenidate—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000389	CcSEcCtD
Methylphenidate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00015	0.000388	CcSEcCtD
Methylphenidate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00015	0.000388	CcSEcCtD
Methylphenidate—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000387	CcSEcCtD
Methylphenidate—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000387	CcSEcCtD
Methylphenidate—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000386	CcSEcCtD
Methylphenidate—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000386	CcSEcCtD
Methylphenidate—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000386	CcSEcCtD
Methylphenidate—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000385	CcSEcCtD
Methylphenidate—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000385	CcSEcCtD
Methylphenidate—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000385	CcSEcCtD
Methylphenidate—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000385	CcSEcCtD
Methylphenidate—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000383	CcSEcCtD
Methylphenidate—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000383	CcSEcCtD
Methylphenidate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000148	0.000382	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000382	CcSEcCtD
Methylphenidate—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000381	CcSEcCtD
Methylphenidate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00038	CcSEcCtD
Methylphenidate—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000379	CcSEcCtD
Methylphenidate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000378	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000378	CcSEcCtD
Methylphenidate—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000377	CcSEcCtD
Methylphenidate—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000377	CcSEcCtD
Methylphenidate—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000376	CcSEcCtD
Methylphenidate—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000376	CcSEcCtD
Methylphenidate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000145	0.000376	CcSEcCtD
Methylphenidate—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000376	CcSEcCtD
Methylphenidate—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000375	CcSEcCtD
Methylphenidate—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000375	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000375	CcSEcCtD
Methylphenidate—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000375	CcSEcCtD
Methylphenidate—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000374	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000374	CcSEcCtD
Methylphenidate—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000374	CcSEcCtD
Methylphenidate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000144	0.000373	CcSEcCtD
Methylphenidate—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000373	CcSEcCtD
Methylphenidate—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000372	CcSEcCtD
Methylphenidate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000372	CcSEcCtD
Methylphenidate—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000372	CcSEcCtD
Methylphenidate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00037	CcSEcCtD
Methylphenidate—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.00037	CcSEcCtD
Methylphenidate—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.00037	CcSEcCtD
Methylphenidate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.00037	CcSEcCtD
Methylphenidate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.00037	CcSEcCtD
Methylphenidate—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000369	CcSEcCtD
Methylphenidate—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000143	0.000369	CcSEcCtD
Methylphenidate—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000369	CcSEcCtD
Methylphenidate—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000368	CcSEcCtD
Methylphenidate—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000368	CcSEcCtD
Methylphenidate—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000367	CcSEcCtD
Methylphenidate—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000367	CcSEcCtD
Methylphenidate—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000367	CcSEcCtD
Methylphenidate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000366	CcSEcCtD
Methylphenidate—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000366	CcSEcCtD
Methylphenidate—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000365	CcSEcCtD
Methylphenidate—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000365	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000365	CcSEcCtD
Methylphenidate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000364	CcSEcCtD
Methylphenidate—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000363	CcSEcCtD
Methylphenidate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000363	CcSEcCtD
Methylphenidate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000362	CcSEcCtD
Methylphenidate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000362	CcSEcCtD
Methylphenidate—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000362	CcSEcCtD
Methylphenidate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00014	0.000362	CcSEcCtD
Methylphenidate—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000361	CcSEcCtD
Methylphenidate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000139	0.000361	CcSEcCtD
Methylphenidate—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.00036	CcSEcCtD
Methylphenidate—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000359	CcSEcCtD
Methylphenidate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000359	CcSEcCtD
Methylphenidate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000358	CcSEcCtD
Methylphenidate—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000358	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000358	CcSEcCtD
Methylphenidate—Rash—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000358	CcSEcCtD
Methylphenidate—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000357	CcSEcCtD
Methylphenidate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000357	CcSEcCtD
Methylphenidate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000357	CcSEcCtD
Methylphenidate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000357	CcSEcCtD
Methylphenidate—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000356	CcSEcCtD
Methylphenidate—Headache—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000355	CcSEcCtD
Methylphenidate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000137	0.000355	CcSEcCtD
Methylphenidate—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000355	CcSEcCtD
Methylphenidate—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000354	CcSEcCtD
Methylphenidate—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000354	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000354	CcSEcCtD
Methylphenidate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000354	CcSEcCtD
Methylphenidate—Rash—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000352	CcSEcCtD
Methylphenidate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000352	CcSEcCtD
Methylphenidate—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000352	CcSEcCtD
Methylphenidate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000352	CcSEcCtD
Methylphenidate—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000352	CcSEcCtD
Methylphenidate—Headache—Abacavir—acquired immunodeficiency syndrome	0.000135	0.00035	CcSEcCtD
Methylphenidate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.00035	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000349	CcSEcCtD
Methylphenidate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000135	0.000349	CcSEcCtD
Methylphenidate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000349	CcSEcCtD
Methylphenidate—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000347	CcSEcCtD
Methylphenidate—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000346	CcSEcCtD
Methylphenidate—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000345	CcSEcCtD
Methylphenidate—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000345	CcSEcCtD
Methylphenidate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000344	CcSEcCtD
Methylphenidate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000344	CcSEcCtD
Methylphenidate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000342	CcSEcCtD
Methylphenidate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000342	CcSEcCtD
Methylphenidate—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000342	CcSEcCtD
Methylphenidate—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000342	CcSEcCtD
Methylphenidate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000342	CcSEcCtD
Methylphenidate—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000341	CcSEcCtD
Methylphenidate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.00034	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000339	CcSEcCtD
Methylphenidate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00013	0.000338	CcSEcCtD
Methylphenidate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000338	CcSEcCtD
Methylphenidate—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000337	CcSEcCtD
Methylphenidate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.000337	CcSEcCtD
Methylphenidate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00013	0.000337	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000336	CcSEcCtD
Methylphenidate—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000335	CcSEcCtD
Methylphenidate—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000334	CcSEcCtD
Methylphenidate—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000333	CcSEcCtD
Methylphenidate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000128	0.000332	CcSEcCtD
Methylphenidate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000331	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000331	CcSEcCtD
Methylphenidate—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.00033	CcSEcCtD
Methylphenidate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000329	CcSEcCtD
Methylphenidate—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000329	CcSEcCtD
Methylphenidate—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000329	CcSEcCtD
Methylphenidate—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000328	CcSEcCtD
Methylphenidate—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000328	CcSEcCtD
Methylphenidate—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000328	CcSEcCtD
Methylphenidate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000328	CcSEcCtD
Methylphenidate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000328	CcSEcCtD
Methylphenidate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000326	CcSEcCtD
Methylphenidate—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000325	CcSEcCtD
Methylphenidate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000324	CcSEcCtD
Methylphenidate—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000321	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000321	CcSEcCtD
Methylphenidate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000319	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000318	CcSEcCtD
Methylphenidate—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000318	CcSEcCtD
Methylphenidate—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000318	CcSEcCtD
Methylphenidate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000316	CcSEcCtD
Methylphenidate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000316	CcSEcCtD
Methylphenidate—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000315	CcSEcCtD
Methylphenidate—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000315	CcSEcCtD
Methylphenidate—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000314	CcSEcCtD
Methylphenidate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000314	CcSEcCtD
Methylphenidate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.000313	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000313	CcSEcCtD
Methylphenidate—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000313	CcSEcCtD
Methylphenidate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000311	CcSEcCtD
Methylphenidate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000311	CcSEcCtD
Methylphenidate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000311	CcSEcCtD
Methylphenidate—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00031	CcSEcCtD
Methylphenidate—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000309	CcSEcCtD
Methylphenidate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000306	CcSEcCtD
Methylphenidate—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000306	CcSEcCtD
Methylphenidate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000305	CcSEcCtD
Methylphenidate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000304	CcSEcCtD
Methylphenidate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000304	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000304	CcSEcCtD
Methylphenidate—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000303	CcSEcCtD
Methylphenidate—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000303	CcSEcCtD
Methylphenidate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000303	CcSEcCtD
Methylphenidate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000303	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000302	CcSEcCtD
Methylphenidate—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000301	CcSEcCtD
Methylphenidate—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000301	CcSEcCtD
Methylphenidate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000297	CcSEcCtD
Methylphenidate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000296	CcSEcCtD
Methylphenidate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000293	CcSEcCtD
Methylphenidate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000293	CcSEcCtD
Methylphenidate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000293	CcSEcCtD
Methylphenidate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000292	CcSEcCtD
Methylphenidate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000292	CcSEcCtD
Methylphenidate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000291	CcSEcCtD
Methylphenidate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.00029	CcSEcCtD
Methylphenidate—Rash—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000289	CcSEcCtD
Methylphenidate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000289	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000288	CcSEcCtD
Methylphenidate—Headache—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000287	CcSEcCtD
Methylphenidate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000286	CcSEcCtD
Methylphenidate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000284	CcSEcCtD
Methylphenidate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000282	CcSEcCtD
Methylphenidate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00028	CcSEcCtD
Methylphenidate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000278	CcSEcCtD
Methylphenidate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000278	CcSEcCtD
Methylphenidate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000275	CcSEcCtD
Methylphenidate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000275	CcSEcCtD
Methylphenidate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000274	CcSEcCtD
Methylphenidate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000273	CcSEcCtD
Methylphenidate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000273	CcSEcCtD
Methylphenidate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000272	CcSEcCtD
Methylphenidate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000272	CcSEcCtD
Methylphenidate—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000271	CcSEcCtD
Methylphenidate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000271	CcSEcCtD
Methylphenidate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000265	CcSEcCtD
Methylphenidate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000263	CcSEcCtD
Methylphenidate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000262	CcSEcCtD
Methylphenidate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000261	CcSEcCtD
Methylphenidate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000261	CcSEcCtD
Methylphenidate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000261	CcSEcCtD
Methylphenidate—Headache—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00026	CcSEcCtD
Methylphenidate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000259	CcSEcCtD
Methylphenidate—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.93e-05	0.000257	CcSEcCtD
Methylphenidate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.78e-05	0.000253	CcSEcCtD
Methylphenidate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.75e-05	0.000252	CcSEcCtD
Methylphenidate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.74e-05	0.000252	CcSEcCtD
Methylphenidate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.000249	CcSEcCtD
Methylphenidate—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.5e-05	0.000246	CcSEcCtD
Methylphenidate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.42e-05	0.000244	CcSEcCtD
Methylphenidate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.41e-05	0.000244	CcSEcCtD
Methylphenidate—Rash—Ritonavir—acquired immunodeficiency syndrome	9.33e-05	0.000242	CcSEcCtD
Methylphenidate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.32e-05	0.000241	CcSEcCtD
Methylphenidate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.3e-05	0.000241	CcSEcCtD
Methylphenidate—Headache—Ritonavir—acquired immunodeficiency syndrome	9.27e-05	0.00024	CcSEcCtD
Methylphenidate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.05e-05	0.000235	CcSEcCtD
Methylphenidate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.98e-05	0.000233	CcSEcCtD
Methylphenidate—Rash—Saquinavir—acquired immunodeficiency syndrome	8.98e-05	0.000233	CcSEcCtD
Methylphenidate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.97e-05	0.000232	CcSEcCtD
Methylphenidate—Headache—Saquinavir—acquired immunodeficiency syndrome	8.92e-05	0.000231	CcSEcCtD
Methylphenidate—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.79e-05	0.000228	CcSEcCtD
Methylphenidate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.64e-05	0.000224	CcSEcCtD
Methylphenidate—Rash—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000222	CcSEcCtD
Methylphenidate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.56e-05	0.000222	CcSEcCtD
Methylphenidate—Headache—Lamivudine—acquired immunodeficiency syndrome	8.51e-05	0.00022	CcSEcCtD
Methylphenidate—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.46e-05	0.000219	CcSEcCtD
Methylphenidate—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.07e-05	0.000209	CcSEcCtD
